Monthly Archives: October 2018

““Previous genetic analyses have demonstrated that two divergent lineages of Pipistrellus kuhlii are spread over Europe and North Africa, and it has been proposed that Pipistrellus maderensis, a taxon endemic to the Canary Archipelago and Madeira, was its sister species. … Continue reading →

Another mechanism of the cholesterol-lowering effect of bezafibrate may be due to the stimulation of cholesterol efflux from hepatocytes to the bile canaliculi Decitabine ic50 by way of the activation of PPARs. Our experiment using HepaRG cells showed significantly up-regulated … Continue reading →

Although in general the NAFLD patients considered asymptomatic, there has no any research study about the quality of life and it’s affecting factors on NAFLD patients in Indonesia. To find out the factors affecting the quality of life on NAFLD … Continue reading →

Percentage necrosis in explanted tumors was correlated with imaging findings. 100%, 50%-99% and

[13] Overall, however, Old World monkeys have, so far, not been relevant as animal models in experimental HBV research, and, with the exception of chimpanzees, animal models with robust persistent infection remain unavailable. Human HBV or HBV variants closely related … Continue reading →

Coronary artery calcium (CAC) scoring has been extensively studied as a powerful, non-invasive tool for cardiovascular risk assessment in the general population. The aim of this study is to investigate whether CAC scoring could predict obstructive CAD in asymptomatic LT … Continue reading →

This has been attributed to activation and differentiation of putative hepatic progenitor cells (HPC) residing in the canals of Hering and/or metaplasia of preexisting mature epithelial cells. A novel analytic approach consisting of multiplex labeling, high-resolution whole-slide imaging (WSI), and … Continue reading →

Others have also reported associations with qHBeAg and clinical responses or virological breakthrough in patients treated with LAM and PEG-IFN.17, 19-21 Most recently, a thorough investigation that included both qHBsAg and qHBeAg was conducted to identify their relationship with intrahepatic … Continue reading →

, MD (Abstract Reviewer) Grants/Research Support: Bristol-Myers Squibb, Bayer Healthcare Pharmaceuticals/Onyx; Consulting: ImClone, Bristol-Myers Squibb, Bayer Healthcare Pharmaceuticals/Onyx, Biocompatibles Lok, Anna S. F., MD (Governing Board, Abstract Reviewer) Grants/Research Support: Abbott, Roche, Bristol-Myers Squibb, Merck, GlaxoSmithKline, Gilead; Advisory Committee or … Continue reading →

NOX does not play a role in experimental steatosis and the generation of ROS in hepatocytes, but exerts a key role in fibrosis. (HEPATOLOGY 2010;) Liver fibrosis is the consequence of chronic liver injury and represents an important cause of … Continue reading →